Ambulatory monitoring of heart sounds via an implanted device is superior to auscultation for prediction of heart failure events

Heart failure (HF) is a complicated syndrome, and despite advances in medical and device-based therapies in the last three decades, the 5-year mortality of patients with HF remains around 50%.1 Increasingly, patients with HF are implanted with implantable cardioverter defibrillators or cardiac resynchronization therapy devices that possess the capability of measuring many diagnostic parameters.

Source: Journal of Cardiac Failure - October 17, 2019 Category: Cardiology Authors: Michael Cao, Roy S. Gardner, Ramesh Hariharan, Devi G. Nair, Christopher Schulze, Qi An, Pramodsingh H. Thakur, Brian Kwan, Yi Zhang, John P. Boehmer Source Type: research